SHIV广HIV-1

Hua Wang1, Cheng Cheng1, James L Dal Santo1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Cell
|October 29, 2024
PubMed
概括

开发一种有效的基于抗体的HIV-1疫苗需要强大的中和反应. 这项研究表明,针对融合位可以诱导大致中和抗体,证明HIV-1疫苗设计的可行性.